The University of Liverpool, Liverpool, United Kingdom.
The University of Nairobi, Nairobi, Kenya.
PLoS One. 2019 Jun 13;14(6):e0217980. doi: 10.1371/journal.pone.0217980. eCollection 2019.
Non-malarial febrile illnesses comprise of almost half of all fever presenting morbidities, among under-five children in sub-Saharan Africa. Studies have reported cases of prescription of antimalarial medications to these febrile under-fives who were negative for malaria. The treatment of these children with antimalarial medications increases incidences of antimalarial drug resistance as well as further morbidities and mortalities, due to failure to treat the actual underlying causes of fever.
To identify clinical and demographic factors associated with treatment type (malarial/non-malarial) of non-malarial febrile illnesses (NMFI) in children aged ≤5 at the Kenyatta National Hospital in Nairobi, Kenya.
A positivist epistemological approach, cross sectional descriptive study design was used. A structured questionnaire was used on a sample of 341 medical records of children aged ≤5 years to extract data on clinical examinations (recorded as yes or no), diagnostic test results, and demographic data on the child's sex and age. Descriptive and inferential analysis was applied to the data.
Prescription of antimalarial drugs despite negative microscopy results was found in 44 (12.9%) of the children, with mortality reported in 48 (14.1%). Assessment of respiratory distress was 0.13 (0.03,0.58) times associated with less likelihood of prescribing an antimalarial in those with a negative microscopy. A male patient was 0.21 (0.05,0.89) times less likely to receive an intravenous antimalarial after a negative microscopy. Patients aged ˂1 with a negative microscopy result were more likely to receive an antimalarial than older children.
There is a need to eliminate incorrect treatment of NMFI with antimalarial medication, while ensuring correct diagnosis and treatment of the specific illness occurs. This requires strengthening and adherence to diagnostic and treatment guidelines of febrile illnesses in under-fives, consequently reducing morbidities and mortalities associated with inadequate management of NMFIs.
在撒哈拉以南非洲地区,五岁以下儿童中,非疟疾发热性疾病几乎占所有发热性疾病的一半。有研究报告称,对这些经检测疟原虫阴性的发热五岁以下儿童开具了抗疟药物。由于未能治疗发热的实际根本原因,用抗疟药物治疗这些儿童会导致抗疟药物耐药性的发生率以及更多的并发症和死亡率增加。
在肯尼亚内罗毕的肯雅塔国家医院,确定与非疟疾性发热性疾病(NMFI)治疗类型(疟疾/非疟疾)相关的临床和人口统计学因素,这些疾病发生在五岁以下的儿童中。
采用实证主义认识论方法,进行了横断面描述性研究设计。对 341 名五岁以下儿童的病历样本使用了一份结构化问卷,以提取关于临床检查(记录为是或否)、诊断测试结果以及儿童性别和年龄的人口统计学数据的信息。对数据进行了描述性和推断性分析。
尽管显微镜检查结果为阴性,但仍发现有 44 名(12.9%)儿童开具了抗疟药物,且有 48 名(14.1%)报告了死亡。评估呼吸窘迫的可能性为 0.13(0.03,0.58)倍,与显微镜检查结果为阴性时不太可能开具抗疟药物相关。显微镜检查结果为阴性的男性患者接受静脉抗疟药物治疗的可能性比阴性患者低 0.21 倍(0.05,0.89)。经显微镜检查结果为阴性的年龄较小的儿童(˂1 岁)比年龄较大的儿童更有可能接受抗疟药物治疗。
需要消除用抗疟药物治疗 NMFI 的不当做法,同时确保对特定疾病进行正确的诊断和治疗。这需要加强和遵守五岁以下儿童发热性疾病的诊断和治疗指南,从而减少与 NMFI 处理不当相关的发病率和死亡率。